← Leaderboards
Soren Mogelsvang
Serpin Pharma, Llc
$259,993
Attributed
$331,478
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $188.5K · FY2013–14$200K$150K$100K$50K$0
'13
'14
Funding mix
By agency
NIH$331,478 · 2
By mechanism
R43$331,478 · 2
Top collaborators
- Cohava Gelber1 shared
Others in their field
Top investigators on “Adult”
- Lawrence Corey · Fred Hutchinson Cancer Center$594,628,824
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$397,114,680
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$388,038,550
- Judith S. Currier · University Of California Los Angeles$251,592,913
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$196,603,707
- Carol Nesel · Westat$188,148,170
Research focus
AdultAffectAmino AcidsAnti-InflammatoryAnti-Inflammatory AgentsApoptosisAutoimmune ProcessAutoimmunityBeta CellCell PhysiologyChildCostCountryDb/Db MouseDiabetes MellitusDoseFunctional DisorderGeneticGlucoseGlucose IntoleranceGlucose ToleranceHealth Care CostsIncidence19 Year Old